VitaGenne Update
VitaGenne Update

Perth, Dec 21, 2018 AEST (ABN Newswire) - MMJ Group Holdings Limited (googlechartASX:MMJ) (googlechartMMJJF:OTCMKTS) ("MMJ") is pleased to attach a regulatory and business update by VitaGenne Inc ("VitaGenne").

MMJ's CEO Jason Conroy commented that "With the signing into law of the Farm Bill by President Trump overnight, we are very excited by the potential for VitaGenne's hemp-derived CBD products business as it prepares for initial sales across the United States in Q1 2019 in line with our investment case."

MMJ has USD$1 million invested in VitaGenne for an 18.2% shareholding.

To view the release, please visit:
http://abnnewswire.net/lnk/M49P0OBZ


About MMJ Group Holdings Ltd

Phytotech Medical ASX:PYL

MMJ Group Holdings Ltd (ASX:MMJ) is a global cannabis investment company. MMJ owns a portfolio of minority investments and aims to invest across the full range of emerging cannabis-related sectors including healthcare, technology, infrastructure, logistics, processing, cultivation, equipment and retail. For MMJ's latest investor presentation and news, please visit: https://www.mmjphytotech.com.au/investors/

https://plus.google.com/112611716213432048650/posts https://www.youtube.com/channel/UCkDxKKC_fe2TdZfeVSpPVhw abnnewswire.com 


Contact

Investor and Media Enquiries:
Jason Conroy
Chief Executive Officer
T: +61-2-8098-0819
E: info@mmjgh.com.au



ABN Newswire
ABN Newswire This Page Viewed:  (Last 7 Days: 20) (Last 30 Days: 78) (Since Published: 9244)